• Angiotensin (1-7): A Smarter Assay Strategy

  2026-09-09

  Angiotensin (1-7) research is moving beyond receptor pharmacology toward sequence-resolved binding and pathway assays. This guide connects Mas receptor biology, peptide handling, and the 2025 spike–receptor study to improve experimental design and interpretation.

• Filipin III for Reliable Membrane Cholesterol Imaging

  2026-09-09

  This scenario-driven guide explains how Filipin III, SKU B6034, supports cholesterol detection in membranes without being mistaken for a direct viability assay. It covers experimental design, handling at −20°C and 37°C, controls, interpretation, and practical vendor selection for biomedical laboratories.

• 5-hme-dCTP and the Context of 5hmC

  2026-09-08

  A translational perspective on how 5-hme-dCTP supports mechanistic 5hmC research, assay validation, and plant drought-response studies while keeping genomic context and analytical limitations in view.

• Amikacin disulfate: Applied Research Workflows

  2026-09-07

  Build more informative antibacterial and protein-binding experiments with Amikacin disulfate, a semisynthetic aminoglycoside antibiotic suited to mechanism, ribosomal interaction, and resistance studies. A multimodal workflow helps separate 16S rRNA-dependent activity from protein complexation and assay interference.

• ROS-Degradable LNPs for Tumor-Selective mRNA Delivery

  2026-09-07

  Cai and colleagues developed a combinatorial library of thioketal-containing, ROS-degradable lipids to improve the preferential delivery of mRNA into tumor cells. The lead lipid, BAmP-TK-12, delivered DUF5-encoding mRNA, depleted mutant RAS, and produced stronger antitumor effects than a small-molecule RAS inhibitor in the reported experimental models.

• Marein Restores Mitoxantrone Sensitivity via ABCG2

  2026-09-05

  The reference study identifies marein, a flavonoid from Coreopsis tinctoria, as a competitive inhibitor of the ABCG2 drug-efflux transporter. By increasing intracellular exposure to ABCG2 substrate drugs, including Mitoxantrone, marein restored drug sensitivity in resistant cancer-cell models and highlighted F439 as an important interaction site.

• ARv7 and EPI-001 in Triple-Negative Breast Cancer

  2026-09-05

  This 2025 study links androgen receptor (AR) and AR variant 7 (ARv7) expression with adverse outcomes in triple-negative breast cancer and examines how Enzalutamide and EPI-001 affect metastatic and epithelial-to-mesenchymal transition biology. Its combination of patient immunohistochemistry, TCGA analysis, wound-healing assays, and molecular measurements highlights ARv7 localization and N-terminal targeting as useful research variables.

• α-Amanitin for RNA Polymerase II Assays

  2026-09-04

  α-Amanitin provides a focused way to interrogate RNA polymerase II-dependent transcription, from cultured-cell gene expression experiments to oocyte chromatin remodeling and embryo development models. This guide converts its mechanism into practical assay workflows, control strategies, and troubleshooting decisions.

• AO/PI Double Staining Kit: Practical Workflow

  2026-09-04

  The AO/PI Double Staining Kit provides a rapid fluorescent cell staining approach for separating viable, apoptotic, and membrane-compromised cell populations in one assay. It is suitable for screening and microscopy-based cell viability workflows, but staining alone should not be treated as definitive proof of a specific death mechanism or used without instrument- and cell-type-specific validation.

• mCherry mRNA for Better Redox Biosensor Assays

  2026-09-03

  mCherry mRNA can serve as more than a fluorescent marker: it can function as a transient delivery and translation control within complex cell assays. This article connects Cap 1 chemistry and modified nucleotides with practical lessons from a bacterial NADH/NAD+ biosensor study.

• TG003 Cdc2-Like Kinase Inhibitor Guide

  2026-09-02

  TG003 is a Cdc2-like kinase inhibitor that preferentially targets Clk1, Clk2, and Clk4 and modulates serine/arginine-rich protein phosphorylation. Its strongest research applications are alternative splicing modulation, splice site selection research, and mechanistic studies connecting CLK2 signaling with platinum resistance.

• Polymyxin B: Microbiome and Infection Workflows

  2026-09-02

  Polymyxin B sulfate supports two complementary research use-cases: membrane-disruption studies in multidrug-resistant Gram-negative bacteria and controlled interrogation of LPS-driven immune signaling. This workflow connects antimicrobial testing, dendritic cell assays, and microbiome-informed immunotherapy experiments while highlighting critical controls and toxicity-related limitations.

• Epinephrine Bitartrate: From Receptor Signal to PK

  2026-09-02

  Epinephrine Bitartrate is a non-selective adrenergic receptor agonist whose effects depend on receptor context, concentration, and exposure route. This translational guide connects receptor pharmacology with canine pharmacokinetic findings to improve assay design and interpretation.

• KX2-391: From Dual Mechanism to Translation

  2026-09-01

  KX2-391 dihydrochloride, also known as Tirbanibulin dihydrochloride, illustrates how a non-ATP-competitive Src strategy can be paired with tubulin disruption to create a translationally versatile research tool. This thought-leadership analysis connects mechanism, assay design, exposure, and indication-specific decision-making across oncology, HBV, and BoNT/A research while distinguishing validated evidence from forward-looking workflow recommendations.

• Substance P: An Interference-Aware Research Guide

  2026-08-31

  Explore Substance P as a tachykinin neuropeptide through an interference-aware framework for pain transmission research, receptor assays, and inflammation studies. This guide connects peptide handling and biological interpretation with lessons from modern spectral classification and machine-learning workflows.

8557 records 1/571 page Next 12345 下5页 Last page